Tech Company Financing Transactions
Putney Funding Round
Putney, based in Portland, received $3 million from private investors.
Transaction Overview
Company Name
Announced On
4/24/2014
Transaction Type
Debt
Amount
$3,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Monument Sq. 400
Portland, ME 04101
USA
Portland, ME 04101
USA
Phone
Website
Email Address
Not Recorded
Overview
Putney is a pharmaceutical company specializing in the development of high quality drugs for pets. We focus on developing generics for frequently used drugs where cost is a barrier to prescribing, compliance or use.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
VP - Bus. Development
Shannon Lancaster
VP - Human Resources
Kelley Shimansky
VP - Regulatory Affairs
Anthony Lucas
Browse more venture capital transactions:
Prev: 4/24/2014: Catalyst Biosciences venture capital transaction
Next: 4/24/2014: Leafit venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs